Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
postdoctoral fellow. This fellowship is directly associated with the FAPESP Thematic Project titled "Brazil as an emerging market democracy variety: between the democratic agenda and the globalization agenda
-
CENTD, a multidisciplinary center studying molecular targets of inflammatory diseases, isoffering a postdoctoral position for 12 months. The project aims to identify and validate newpharmacological
-
position within a Research Infrastructure? No Offer Description The School of Electrical and Computer Engineering (FEEC) and the Agricultural Engineering School (FEAGRI), both from the State University
-
30 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Engineering Researcher Profile Established Researcher (R3) Country Brazil Application Deadline
-
scope of the Offshore Technology Innovation Center (OTIC), an Engineering Research Center (ERC) supported by the São Paulo Research Foundation (FAPESP) in partnership with Shell Group and hosted by
-
CENTD, a multidisciplinary center studying molecular targets of inflammatory diseases, is offering a postdoctoral position for 12 months. The project aims to identify and validate new pharmacological
-
of São Paulo (USP, Ribeirão Preto, Brazil). Applications must be sent to the e-mail ebert@ffclrp.usp.br with the title “Postdoctoral Application”, with the following documents attached: 1. Curriculum
-
/function and engineering of luciferases; applications in biosensors, bioassays, and environmental bioindication,” which involves gene target selection, cloning, expression, purification, and functional
-
4 Sep 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Environmental science Researcher Profile Established Researcher (R3) Country Brazil Application Deadline 15 Oct 2025 - 23:59 (UTC) Type of Contract To be defined Job Status Not Applicable Is the...
-
cancer. CRIO is an Engineering Research Center (ERC) supported by the São Paulo Research Foundation (FAPESP) and GSK, the result of a partnership between the Albert Einstein Institute for Education and